SOURCE: BioPharmetics, Inc.

May 22, 2006 10:45 ET

BioPharmetics, Inc. Receives Large Order From Major New York Drug Retail Chain

NORTH HOLLYWOOD, CA -- (MARKET WIRE) -- May 22, 2006 -- BioPharmetics, Inc. (PINKSHEETS: BPMT) announced the company has received a large order from Duane Reade, a major New York Pharmacy retailer with over 230 stores in commercial and residential neighborhoods throughout New York.

"We're very excited to have our cosmetic products placed in the Duane Reade chain throughout the greater New York area," stated Paul D. Lisenby, CEO of BioPharmetics, Inc. Mr. Lisenby adds, "This order will allow our company to have a major retail presence in one of the largest markets in the U.S. Our attendance of the ECRM Show back in February has continued to allow the company to gain retailers throughout the U.S. and we should see many additional orders coming in the next few months from other retailers that attended the show and have requested products to place in their stores."

For more information about Duane Reade, please visit their website at www.duanereade.com

For more information about all of BioPharmetics, Inc. products, please visit the website at www.biopharmetics.com

About BioPharmetics, Inc. (PINKSHEETS: BPMT)

BioPharmetics, Inc. is a manufacturer and distributor of quality pharmaceutical, cosmetic, and anti-aging products. The company has three divisions: biotechnology, pharmaceuticals, and cosmetics/cosmeceuticals, working in unison to develop, manufacture, and distribute, high-quality products in the retail, wholesale, and professional markets. Brands currently offered include Toma™, Isseo™, Molo Africa™, Micha™, and Natural Angel™. BioPharmetics, Inc. also private labels many brands of cosmetics and cosmeceuticals for salons and retail stores as well as compounding specialized prescriptions for doctors nationwide.

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

Contact Information

  • Contact:
    FutureTechIR for BioPharmetics
    Investor Relations
    (817) 812-2105 or
    (727) 417-9338